
Surf Therapeutics is a clinical-stage company pioneering the development of non-invasive ultrasound neuromodulation technologies to modulate immune-related pathways. Its SUSTAIN platform is designed to engage the body's natural anti-inflammatory pathway without surgery or implanted hardware, enabling safe, at-home use and scalable access to therapy.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/17/26 | $6,000,000 | Seed |
Elderberry Ventures Evoce Capital General Inception Mir Imran SOSV TMC Venture Fund VVP Ignite | undisclosed |